SC 13D/A | 2018-12-13 | BAUPOST GROUP LLC/MA | KERYX BIOPHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13D/A | 2018-06-29 | BAUPOST GROUP LLC/MA | KERYX BIOPHARMACEUTICALS INC | 61,374,013 | 39.4% | EDGAR |
SC 13D/A | 2018-05-10 | BAUPOST GROUP LLC/MA | KERYX BIOPHARMACEUTICALS INC | 61,374,013 | 39.7% | EDGAR |
SC 13G/A | 2018-03-08 | BlackRock Inc. | KERYX BIOPHARMACEUTICALS INC | 5,913,636 | 5.0% | EDGAR |
SC 13G/A | 2018-02-14 | ABRAMS CAPITAL MANAGEMENT, L.P. | KERYX BIOPHARMACEUTICALS INC | - | - | EDGAR |
SC 13G/A | 2018-02-09 | VANGUARD GROUP INC | KERYX BIOPHARMACEUTICALS INC | 7,893,859 | 6.6% | EDGAR |
SC 13G | 2018-02-01 | BlackRock Inc. | KERYX BIOPHARMACEUTICALS INC | 6,097,948 | 5.1% | EDGAR |
SC 13G/A | 2017-11-20 | ABRAMS CAPITAL, LLC | KERYX BIOPHARMACEUTICALS INC | - | - | EDGAR |
SC 13G/A | 2017-06-08 | BlackRock Inc. | KERYX BIOPHARMACEUTICALS INC | 5,252,010 | 4.8% | EDGAR |
SC 13G/A | 2017-02-10 | VANGUARD GROUP INC | KERYX BIOPHARMACEUTICALS INC | 6,545,762 | 6.2% | EDGAR |
SC 13G/A | 2017-02-10 | ABRAMS CAPITAL MANAGEMENT, L.P. | KERYX BIOPHARMACEUTICALS INC | - | - | EDGAR |
SC 13G | 2017-01-30 | BlackRock Inc. | KERYX BIOPHARMACEUTICALS INC | 5,393,515 | 5.1% | EDGAR |
SC 13G/A | 2016-07-08 | BlackRock Inc. | KERYX BIOPHARMACEUTICALS INC | 4,692,588 | 4.4% | EDGAR |
SC 13D/A | 2016-06-01 | BAUPOST GROUP LLC/MA | KERYX BIOPHARMACEUTICALS INC | 59,214,137 | 42.5% | EDGAR |
SC 13G | 2016-02-12 | ABRAMS CAPITAL MANAGEMENT, L.P. | KERYX BIOPHARMACEUTICALS INC | - | - | EDGAR |
SC 13G/A | 2016-02-10 | VANGUARD GROUP INC | KERYX BIOPHARMACEUTICALS INC | 6,002,097 | 5.7% | EDGAR |
SC 13G/A | 2016-02-09 | FRANKLIN RESOURCES INC | KERYX BIOPHARMACEUTICALS INC | 836,515 | 0.8% | EDGAR |
SC 13G/A | 2016-01-26 | BlackRock Inc. | KERYX BIOPHARMACEUTICALS INC | 5,620,225 | 5.3% | EDGAR |
SC 13D | 2015-10-20 | BAUPOST GROUP LLC/MA | KERYX BIOPHARMACEUTICALS INC | 42,016,276 | 34.6% | EDGAR |
SC 13G | 2015-02-10 | VANGUARD GROUP INC | KERYX BIOPHARMACEUTICALS INC | 5,690,238 | 6.2% | EDGAR |